|Year : 2017 | Volume
| Issue : 3 | Page : 239-245
Epidemiological and laboratorial profile of patients with isolation of nontuberculous mycobacteria
Heloisa Silveira Paro Pedro1, Andréa Gobetti Vieira Coelho2, Isabela Mazuco Mansur1, Ana Carolina Chiou2, Maria Izabel Ferreira Pereira1, Naiara Cristina Ule Belotti1, Manuela Galloy Sanches Ismael3, Maria Rita de Cássia Oliveira Cury4, Susilene Maria Tonelli Nardi1, Érica Chimara5
1 Instituto Adolfo Lutz, Núcleo de Ciências Biomédicas, Laboratório de Micobactérias do Instituto Adolfo Lutz, de São José do Rio Preto, SP Rua Alberto Sufredine Bertoni, 2325, Maceno, São José do Rio Preto, São Paulo, Brazil
2 Instituto Adolfo Lutz, Núcleo de Ciências Biomédicas, Laboratório de Micobactérias do Instituto Adolfo Lutz de Santos, SP Rua Silva Jardim, 90, Vila Matias, Santos, Brazil
3 Mercartor, Rua Voluntarios de Sao Paulo 3439, Sao Jose do Rio Preto, Brazil
4 Ambulatório de Tuberculose e Hanseníase, Tv. Tamôio, 3571, Vila Fioresi, São José do Rio Preto, Brazil
5 Instituto Adolfo Lutz, Núcleo de Tuberculose e Micobacterioses, IAL Central São Paulo, SP Av. Dr. Arnaldo, 355 Cerqueira César, São Paulo, Brazil
|Date of Web Publication||31-Jul-2017|
Heloisa Silveira Paro Pedro
Núcleo de Ciências Biomédicas, Laboratório de Micobactérias do Instituto Adolfo Lutz de São José do Rio Preto, SP Rua Alberto Sufredine Bertoni, 2325, Maceno. São José do Rio Preto, São Paulo
Source of Support: None, Conflict of Interest: None
Background: An increase in NTM diseases in the international scenario has been observed in recent years. Aims: To analyze the epidemiological and laboratory profiles of patients with isolation of nontuberculous mycobacteria (NTM) over one decade. A retrospective analysis of records of a mycobacterial reference laboratory found 135 cases with isolation of NTM. Methods: Clinical and epidemiological data were collected from the records of government health clinics and from the State notification system (TBWEB). The cases were geocoded by location based on the street address in the Mercator Transverse Universal projection, Datum SAD/69 and MapInfo software. Results: Most patients were male (66.7%), older than 50 years (40%) and had only completed elementary schooling (38.5%). Associated health problems were found in 71.8% of the subjects, with 43.7% being HIV positive and 25.9% having had tuberculosis in the past. Hospitals were the most able institutions to diagnose cases (45.2%). Sputum was the most common material tested (63.0%) with the bacilloscopy being positive in 33.3% of cases. The most common mycobacteria species in the region were Mycobacterium avium and M. abscessus/M. massiliense/M. bolletii. When the regional reference municipality was analyzed, M. avium and M. fortuitum were the most common species isolated in the urban area. Conclusions: In the study region, mycobacteriosis most affected adult males with low schooling. Most patients presented comorbidities in particular co-infection with the HIV virus. M. avium is the most prevalent species in the region with the M. abscessus/M. massiliense/M. bolletii species being the main cause of nosocomial infections.
Keywords: Clinical laboratory techniques, epidemiology, Mycobacterium avium, nontuberculous mycobacteria, retrospective analysis
|How to cite this article:|
Pedro HS, Coelho AG, Mansur IM, Chiou AC, Pereira MI, Belotti NC, Ismael MG, Cury MR, Nardi SM, Chimara É. Epidemiological and laboratorial profile of patients with isolation of nontuberculous mycobacteria. Int J Mycobacteriol 2017;6:239-45
|How to cite this URL:|
Pedro HS, Coelho AG, Mansur IM, Chiou AC, Pereira MI, Belotti NC, Ismael MG, Cury MR, Nardi SM, Chimara É. Epidemiological and laboratorial profile of patients with isolation of nontuberculous mycobacteria. Int J Mycobacteriol [serial online] 2017 [cited 2022 Jul 4];6:239-45. Available from: https://www.ijmyco.org/text.asp?2017/6/3/239/211936
| Introduction|| |
Nontuberculous mycobacteria (NTMs) are widely dispersed in the environment, in natural and drinking water, and in soil and aerosols; they have already been isolated in several animal species and from different sites of the human body. The importance of diseases caused by NTM has been increasing progressively,,,,, mainly due to the improvement in the diagnosis of mycobacteria, with the typification of different species that were previously difficult to identify.
Despite the increase in the number of species isolated, the true clinical significance of each is still very difficult and controversial. Most species are saprophytic and replicate in natural environments; however, a few adapt to the intracellular environment and can cause disease.
Since human is not the host of choice for NTM, infections are opportunistic. Thus, environmental sources, such as inoculation through trauma, inhalation of aerosols, and contaminated medical instruments, are the most common forms of transmission. Several factors may lead to increased susceptibility to NTM infection, in particular preexisting lung disease, immunosuppression, and genetic defects related to cell-mediated immunity.
In Brazil, as in most developing countries, the routine diagnosis of mycobacteriosis is based on direct microscopic examination of sputum and cultures, the most sensitive method, especially in samples from paucibacillary patients. NTM isolation from nonsterile clinical specimens may mean transient colonization or contamination and not necessarily disease; thus, clinical-laboratory diagnosis is important to confirm mycobacteriosis and to establish the therapeutic strategy.
NTM isolation rates are quite different between the Brazilian regions. In São Paulo State, there are differences in isolation frequencies, with predominance of Mycobacterium avium,,, and Mycobacterium kansasii in different municipalities.
This study aimed to analyze the epidemiological and laboratory profiles of patients with NTM infections over one decade in an important region of São Paulo State.
| Methods|| |
This retrospective study included all patients with NTMs living in 102 municipalities that constitute the XV Regional Health Department of São José do Rio Preto (SJRP) tested by the Adolfo Lutz Institute of São José do Rio Preto (IAL-SJRP) from 2000 to 2009. IAL-SJRP is a regional reference laboratory for the diagnosis of mycobacteria.
The regional reference municipality (SJRP) is in a region that borders two other states and is an important administrative, medical, service center. It has a high acquired immunodeficiency syndrome (AIDS) coefficient, which influences the prevalence of tuberculosis (TB).
Patients were identified from records of the Mycobacteria Laboratory of IAL-SJRP. Subsequently, clinical and epidemiological data were retrieved from medical records from government health clinics and the São Paulo State Notification System-TBWEB (http://www.cvetb.saude.sp.gov.br/tbweb/).
Analysis of the clinical, epidemiological, and laboratory profile of patients was based on sex, age, other associated pathological conditions, schooling, profession, address, clinical specimen, bacilloscopy results, isolated NTM species, number of isolates, history of TB, treatment given, X-ray results, diagnostic criteria, notification at TBWEB, and type of closure of the case.
Pulmonary and extrapulmonary clinical specimens were included. According to the bacteriological criteria established by the American Thoracic Society, a patient has mycobacteriosis when the same infectious agent is identified in more than one sample from a nonsterile site or is identified in only one sample from a sterile site. Due to the large number of cases, patients with single isolates from a nonsterile site were included in the study if they had clinical criteria compatible with the disease or an X-ray suggestive of TB.
For the classification of cases, over 15-year-old patients with laboratory diagnosis confirmed by culture and conclusive identification of NTM were considered “confirmed cases” of mycobacteriosis. Patients with only one nonsterile site isolation without the clinical criteria or an X-ray suggestive of the disease were considered “suspected cases” and included in the overall analysis.
Bacilloscopy and cultures were performed at IAL-SJRP according to the methodology recommended by the Brazilian Ministry of Health. Bacterial identification was performed at the Central IAL in São Paulo using the polymerase chain reaction-restriction enzyme analysis (PRA-hsp65) method and phenotypic identification.,
The designation of the group “Mycobacterium abscessus/Mycobacterium massiliense/Mycobacterium bolletii” was used because some isolates were identified only based on phenotypic evidence, which does not differentiate between these species.
Statistical analyses used the Epi-Info statistical software version 184.108.40.206 (Atlanta, Geórgia, EUA). All cases were geocoded by location based on street address in the Universal Transverse Mercator projection, Datum SAD/69 made available by the city hall of SJRP. Mapinfo software tools were used to prepare thematic maps.
This study is part of a research project (Protocol number is 136487/2010).
| Results|| |
In the period from 2000 to 2009, isolates of NTMs were found in 135 patients; 74 (55%) were registered from 2000 to 2003.
The study population was predominantly male, older than 50 years, and presented some type of associated comorbidity [Table 1].
|Table 1: Clinical and sociodemographic characteristics of patients with isolation of nontuberculous Mycobacteria in the XV Regional Health Department in Sao Jose do Rio Pre to during the period 2000-2009|
Click here to view
Notification of cases
TBWEB notification occurred for 94 (69.6%) patients with 5 (3.7%) being notified twice. Notification is made based on positive NTM bacilloscopy results updated in cases of mycobacteriosis. In these cases, the natural outcome is a change in the diagnosis as found for 32 (23.7%) patients. However, other outcomes were found: 34 (25.2%) cases of cure, 11 (8.1%) cases of death from other causes, two (1.5%) deaths due to TB, one (0.7%) case abandoned treatment, one (0.7%) case transferred, and for 13 (9.6%) patients, there was no closure despite the notification.
Hospitals had the highest percentages of diagnosis (45.2%; n = 61) and notifications (49.2%; n = 30). Specialist outpatient clinics diagnosed 44 cases (32.6%) and notified 40 (90%), first aid posts diagnosed 6 (4.4%) cases and notified all of them, and 16 (11.9%) cases were identified in government health clinics that notified 12 (75%). This information was missing from 8 (5.9%) medical records.
The mean duration of treatment for mycobacterial cases was 15 months (range: 34–1700 days) from the release of the microorganism identification report to the conclusion of the case on the TBWEB.
Analysis of medical records
Information on occupations was found in 43% (n = 58) of the cases: construction workers 29.3% (n = 17), self-employed 20.7% (n = 12), registered employees 19.0% (n = 11), agricultural workers 13.8% (n = 8), housecleaners 10.4% (n = 6), retired 1.7% (n = 1), two students (3.4%), and one homeless (1.7%). Regarding previous history of illness, 35 patients (25.9%) had had TB. The mean time between the TB and the discovery of NTM varied from 5 months to 60 years (mean 6.6 ± 11.7 years; median 3.0 years).
Among the cases evaluated, 60 (44.4%) had X-rays with suspicion of TB and 20 (14.8%) with suspicion of TB with cavity. However, 14 (10.4%) did not perform an X-ray, 19 (14.1%) had no information on X-rays, and 12 (8.9%) had normal X-rays, and for 10 (7.4%), the X-ray identified other conditions.
For cases that recorded the time between the onset of symptoms and the diagnosis of NTM (n = 58), the mean time between events was 83.5 days (range: 6–660 days).
Of the 135 patients, 76 (56.3%) were not treated for mycobacteriosis and 18 (13.3%) had no information on the drug used for the treatment. Of the 41 (30.4%) patients who were treated for NTMs, three were treated with regimen I (rifampicin, isoniazid, and pyrazinamide), eight were treated with the IR regimen (rifampicin, isoniazid, pyrazinamide, and ethambutol) and thirty were treated with alternative regimens that associated or included other drugs such as ciprofloxacin, amikacin, clofazimine, azithromycin, cephalexin, and clarithromycin. Clarithromycin was used in 14 patients.
The total number of patients with positive bacilloscopy was 45/135 (33.3%); most tested sputum.
The results showed that M. avium was the most frequently isolated species (33.3%). However, frequency analysis from year to year showed that the isolation of this species was decreasing, whereas the isolation of the M. abscessus/M. massiliense/M. bolletii group increased from 2007 [Figure 1]. Of the 24 cases of M. abscessus/M. massiliense/M. bolletii in bronchial lavage, 20 were from the same hospital, isolated in 2008 (n = 5) and 2009 (n = 15).
|Figure 1: Frequency of isolation of mycobacteria species at the Adolfo Lutz Institute, São José do Rio Preto from 2000–2009|
Click here to view
All 13 (9.6%) cases with disseminated disease were HIV positive; M. avium was isolated in 11 cases, M. kansasii in one, and Mycobacterium fortuitum in one; five patients had concomitant Mycobacterium tuberculosis (MT) and NTM isolated from sputum; four were HIV positive, three of whom were also drinkers and one took cocaine [Table 2].
|Table 2: Clinical and bacteriological characteristics of the cases with concomitant isolation of Mycobacterium tuberculosis and nontuberculous Mycobacteria|
Click here to view
More than one NTM isolate was obtained from 47 patients; the same species was identified in different isolates in 63.8% (30/47) of the patients and different species were found in 36.2% (17/47) of the patients. The maximum number of isolates in one individual was four, observed in 10.6% (5/47) of the cases.
It was not possible to confirm mycobacteriosis in 5.2% of the patients (n = 7), who were classified as “suspected cases” due to one isolation of NTM from a nonsterile site and absence of clinical and radiological findings in the medical records.
[Table 3] lists the most commonly investigated sites for the isolation of NTMs. It is interesting to note the isolation of M. avium and M. fortuitum in three patients.
|Table 3: Absolute n (%) of nontuberculous Mycobacteria species isolated between 2000 and 2009 from patients of Dispositional Resilience Scale|
Click here to view
As the study region is extensive with 102 municipalities and as most of the cases were residents in SJRP (75/135%–55.5%), only patients with full addresses in this urban area (n = 65) are shown in the maps in [Figure 2] with annual distribution. M. avium and M. fortuitum were the most common species isolated.
|Figure 2: Species of nontuberculous mycobacteria identified over ten years in the diagnosis of tuberculosis and mycobacteriosis in the regional reference municipality of the Regional Health Department-XV|
Click here to view
Cases were observed throughout the municipality, without predominance of any region. However, the isolation of NTM was more common in two specific periods (2000–2003 and 2009).
| Discussion|| |
An increase in NTM diseases in the international scenario has been observed in recent years ,,,, including at sites that have been rarely studied. Epidemiological studies on the occurrence of mycobacteriosis in Brazil are scarce.
AIDS was one of the factors that contributed to the increase of NTMs in developed countries ,,, and may also have contributed to the occurrence of NTMs in this region.
The high mean age of the patients with mycobacteriosis with the majority being male shows a similar profile to that reported in the literature.,,,, Here is, however, a paucity of studies analyzing the schooling and profession of patients perhaps because profession is rarely included in medical records.
It is not mandatory to notify mycobacteriosis in Brazil, except for cases of fast-growing mycobacteria after surgery. Although 30.4% of the cases were not reported, the high percentage of cases reported to the TBWEB system without a “change of diagnosis” reveals that the patient is probably not being treated adequately.
The highest percentage of cases diagnosed in this study was discovered at tertiary care hospitals where the patient is usually diagnosed in a serious condition. This suggests that the diagnosis had been delayed, a fact that may explain the long time between the onset of symptoms and the date of diagnosis.
Although chronic lung disease is the most common clinical manifestation of NTMs, the decision to treat patients who have symptoms is still a concern since the identification of mycobacteria can take days or weeks. In the 1950s, with the introduction of effective treatment for TB, cultures became routine and it was found that some cases diagnosed as TB were in fact NTMs. The medical records in this study showed that although the initial diagnosis based on clinical and radiological symptoms suggested TB, a species of NTM was found, showing the importance of identification for a satisfactory outcome.
More than half the patients did not receive NTM treatment (56.3%), a fact that is not investigated in this study. This suggests that the physician's decision was not to carry out treatment when there is only one isolate from a nonsterile site. Studies show that many patients do not treat mycobacteriosis., For patients that were treated in this study, the treatment time varied probably because therapy is complex as NTMs are naturally resistant or have low sensitivity to TB drugs and have different patterns of resistance., The types of drugs used in these patients are those recommended by the national literature.
The high occurrence of NTM cases before 2003 can possibly be explained by the introduction of highly active antiretroviral therapy, which reduced the number of cases of disseminated disease in the region.
The percentage of positive bacilloscopies (33.3%) was higher than those found in studies in India (20%) and Greece (10%) but lower than one study carried out in Italy (53.3%). As generally the bacilloscopy is negative and the result of the culture takes a long time, the patient may no longer be found to treat mycobacteriosis after being discharged.
M. avium, a slow-growing NTM, was responsible for 33.3% of all cases. Other studies reported that this agent was prevalent in isolations of NTMs.,,,,,,,,M. avium can cause disease in individuals with or without previous lung disease. Disseminated disease can occur in patients with AIDS and in patients with abnormalities of the interleukin-12 and interferon gamma receptors., In the present study, the occurrence of disseminated disease caused by M. avium was found in 11 cases, all of which were HIV positive. It was not possible to establish an epidemiological connection between the cases of M. avium due to their occurrence in diverse and unrelated sites.
Isolation of the M. abscessus/M. massiliense/M. bolletii group in the bronchoalveolar lavage of individuals from the same hospital, mostly in 2009, suggests an outbreak. This rapidly growing mycobacterium is commonly associated with outbreaks of nosocomial infections after invasive procedures,, probably due to failure in the disinfection process and not to sterilization. The analysis of the geographical distribution of NTMs around the world and the possible sources of infection may be the guiding principles for the prevention of the disease.
There is geographic variability in the prevalence and distribution of species responsible for diseases caused by NTMs in São Paulo State, such as Mycobacteria gordonae,M. kansasii, and M. avium. In this study region, the most frequent species was M. avium in sputum, followed by M. abscessus/M. massiliense/M. bolletii in bronchoalveolar lavage; another common species was M. fortuitum. This species has been reported as an agent of pulmonary diseases but mainly in cases of infections after surgery and related to the use of catheters., On the contrary, one study conducted in the Middle East found that Mycobacterium chelonae 50% was the most common among fast-growing NTMs with Mycobacterium simiae (42.8%) being the most frequent among slow-growing NTMs.
The majority of carriers of NTM isolates from nonsterile materials presented only one positive culture for mycobacteria, which may characterize transitory contamination or colonization. However, patients with single isolates presented clinical findings compatible with disease and/or an association with other comorbidities that may affect the immune system. Other confirmatory criteria such as positive bacilloscopy or radiological diagnosis were also observed. Previous studies in our region reported the same difficulty in relation to the number of isolates in nonsterile samples , as have other authors., This fact shows one operational difficulty in the diagnosis of NTM in Brazil that recommends the request for new samples to confirm cases.
The occurrence of mixed infections of MT with other mycobacteria may have occurred due to the HIV status of four of these patients. However, the presence of MT and M. gordonae in an immunocompetent patient may have occurred due to sample contamination as M. gordonae is rarely correlated to the disease. We should remember that the lesion caused by MT is an open door for mycobacteriosis. Therefore, knowing the TB history of patients is important for the suspicion of NTM infections. In a study in Pará, Brazil, Fusco da Costa et al. found a 76% risk for lung disease due to NTMs in patients who had had TB. As in this study, Lima et al. in Rondônia, Brazil, found the presence of more than one NTM species in the same patient and found three cases of NTM and MT coinfection.
Among the limitations of the study, we must highlight those resulting from incomplete records, making the analysis of variables difficult.
| Conclusion|| |
Mycobacteriosis mainly affects men, over 50-year olds, and individuals with a low level of schooling.
Most patients present an associated pathology, with coinfection by the HIV virus being the most common.
The laboratory profile showed a regional panorama of NTM species with two realities. the first presents M. avium as the prevalent species, and in a population with a high incidence of HIV, its identification is mandatory to establish the correct therapy. The second reality reflects the region's characteristic of being an important medical and service center, in which the M. abscessus/M. massiliense/M. bolletii species are the main cause of nosocomial infections. This shows that surveillance should be increased as a preventive measure.
NTMs may be underdiagnosed because of the difficulty in obtaining data to establish the disease or simply because it is a transient infection or colonization.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Falkinham JO 3rd
. Current epidemiologic trends of the Nontuberculous Mycobacteria (NTM). Curr Environ Health Rep 2016;3:161-7.
Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: A review. Clin Chest Med 2015;36:13-34.
Lake MA, Ambrose LR, Lipman MC, Lowe DM. Why me, why now? Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med 2016;14:54.
Ryu YJ, Koh WJ, Daley CL. Diagnosis and treatment of nontuberculous mycobacterial lung disease: Clinicians' perspectives. Tuberc Respir Dis (Seoul) 2016;79:74-84.
Yeung MW, Khoo E, Brode SK, Jamieson FB, Kamiya H, Kwong JC, et al.
Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review. Respirology 2016;21:1015-25.
Wildner LM, Nogueira CL, Souza BS, Senna SG, Silva RM, Bazzo ML. Mycobacteria: Epidemiology and diagnosis. Rev Patol Trop 2011;40:207-29.
Marinho A, Fernandes G, Carvalho T, Pinheiro D, Gomes I. Nontuberculous mycobacteria in non-AIDS patients. Rev Port Pneumol 2008;14:323-37.
Cabral DB, Andrade D. Non-tuberculous mycobacteria in surgeries: Clear challenge of coping in Brazil? Acta Paul Enferm 2011;5:715-20.
Falkinham JO 3rd
. Epidemiology and ecology of nontuberculous mycobacteria. Rev Port Pneumol 2010;16SA:S27-30.
Ministry of Health. Department of Health Surveillance. Department of Epidemiological Surveillance. National Manual of Laboratory Surveillance of Tuberculosis and Other Mycobacteria. Brasília, DF: Ministry of Health; 2008.
Center for Epidemiological Surveillance of the State of São Paulo– CES. Recommendations for the diagnosis and treatment of non-tuberculous mycobacteria in the State of São Paulo. São Paulo; 2008.
Ueki SY, Martins MC, Telles MA, Virgilio MC, Giampaglia CM, Chimara E, et al
. Non-tuberculous mycobacteria: Species diversity in the State of São Paulo. Bras Patol Med Lab 2005;41:1-8.
Bensi EP, Panunto PC, Ramos Mde C. Incidence of tuberculous and non-tuberculous mycobacteria, differentiated by multiplex PCR, in clinical specimens of a large general hospital. Clinics (Sao Paulo) 2013;68:179-84.
Pedro HS, Pereira MI, Goloni MR, Ueki SY, Chimara E. Isolation of non-tuberculous mycobacteria in São José do Rio Preto between 1996 and 2005. J Bras Pneumol 2008;34:950-5.
Zamarioli LA, Coelho AG, Pereira CM, Nascimento AC, Ueki SY, Chimara E. Descriptive study of the frequency of nontuberculous mycobacteria in BaixadaSantista(SP). J Bras Pneumol 2008;34:590-4.
Municipal Secretariat of Planning and Strategic Management Economic Environment 2013. Economic Environment. 28th
ed. Municipal Secretariat of Planning and Strategic Management of São José do Rio Preto; 2014.
Santos ML, Ponce MA, Vendramini SH, Villa TC, Santos NS, Wysocki AD, et al
. The epidemiological dimension of TB/HIV co-infection. Rev Lat Am Enfermagem 2009;17:683-8.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al.
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
Chimara E, Ferrazoli L, Ueky SY, Martins MC, Durham AM, Arbeit RD, et al.
Reliable identification of mycobacterial species by PCR-restriction enzyme analysis (PRA)-hsp65 in a reference laboratory and elaboration of a sequence-based extended algorithm of PRA-hsp65 patterns. BMC Microbiol 2008;8:48.
Garg P. Nontuberculous mycobacteria in fistula-in-ano: A new finding and its implications. Int J Mycobacteriol 2016;5:276-9. [Full text]
Seddon P, Fidler K, Raman S, Wyatt H, Ruiz G, Elston C, et al.
Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009. Emerg Infect Dis 2013;19:1128-30.
Falkinham JO 3rd
. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis 2011;17:419-24.
Kobashi Y, Mouri K, Obase Y, Kato S, Oka M. Clinical analysis of pulmonary nontuberculous mycobacterial disease diagnosed as coincidental pulmonary infection due to Mycobacterium
species. Open J Respir Dis 2013;3:107-12.
Scappaticcio AB, Velasco MR, Leiva TC, Rodríguez JCD. Frequency of environmental mycobacteria in Chile in 2008. Rev Chil Enferm Respir 2011;27:214-22.
Bertoletti AC, Alves KJ, Chimara E, Aily DC. Isolation of mycobacteria from clinical samples in the Rio Claro region: Frequency analysis. Rev Inst Adolfo Lutz 2011;70:622-30.
Dabó SV, Marinho A, Ramos A, Carvalho T, Ribeiro M, Amorim A. Micobactérias não tuberculosas em espécimes respiratórios: Significado clínico em um hospital terciário no norte de [Portugal Nontuberculous mycobacteria in respiratory specimens: Clinical significance at a tertiary care hospital in the North of Portugal Hans]. J Bras Pneumol 2015;41:292-4.
Antunes A, Viveiros F, Carvalho A, Duarte R. Non-tuberculous mycobacterioses: From clinical manifestations to treatment. Arq Med 2012;26:25-30.
Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al.
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010;182:970-6.
Mwikuma G, Kwenda G, Hang'ombe BM, Simulundu E, Kaile T, Nzala S, et al.
Molecular identification of non-tuberculous mycobacteria isolated from clinical specimens in Zambia. Ann Clin Microbiol Antimicrob 2015;14:1.
Shenai S, Rodrigues C, Mehta A. Time to identify and define non-tuberculous mycobacteria in a tuberculosis-endemic region. Int J Tuberc Lung Dis 2010;14:1001-8.
Panagiotou M, Papaioannou AI, Kostikas K, Paraskeua M, Velentza E, Kanellopoulou M, et al.
The epidemiology of pulmonary nontuberculous mycobacteria: Data from a general hospital in Athens, Greece, 2007-2013. Pulm Med 2014;2014:894976.
D'Antonio S, Rogliani P, Paone G, Altieri A, Alma MG, Cazzola M, et al.
An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network. Int J Mycobacteriol 2016;5:244-7.
Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M. Nontuberculous mycobacteria in Middle East: Current situation and future challenges. Int J Mycobacteriol 2015;4:7-17. [Full text]
Zamarioli LA, Coelho AG, Pereira CM, Ferrazoli L, Bammann RH. Laboratory identification of mycobacteria in respiratory samples from HIV-positive patients suspected of tuberculosis. Rev Soc Bras Med Trop 2009;42:290-7.
Rindi L, Garzelli C. Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. BMC Infect Dis 2016;16:44.
Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, et al.
Infection with Mycobacterium avium
complex in patients without predisposing conditions. N
Engl J Med 1989;321:863-8.
Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al.
Amutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N
Engl J Med 1996;335:1941-9.
Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11:321-33.
Rivera-Olivero IA, Guevara A, Escalona A, Oliver M, Pérez-Alfonzo R, Piquero J, et al.
Soft-tissue infections due to non-tuberculous mycobacteria following mesotherapy. What is the price of beauty. Enferm Infecc Microbiol Clin 2006;24:302-6.
Fontana RT. The mycobacterias of rapid growth and the hospital infection: A public health problem. Rev Bras Enferm 2008;61:371-6.
Pitombo MB, Lupi O, Duarte RS. Rapidly growingmycobacterium infections resistant to disinfectants: A national problem? Rev Bras Ginecol Obstet 2009;31:529-33.
Halstrom S, Price P, Thomson R. Review: Environmental mycobacteria as a cause of human infection. Int J Mycobacteriol 2015;4:81-91. [Full text]
Brown-Elliott BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 2012;25:545-82.
Santos DR, Lourenço MC, Coelho FS, Mello FC, Duarte RS. Resistance profile of Mycobacterium fortuitum strains isolated from clinical specimens. J Bras Pneumol 2016;42:299-301.
Velayati AA, Farnia P, Mozafari M, Malekshahian D, Seif S, Rahideh S, et al.
Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city. PLoS One 2014;9:e114428.
Pedro HS, Pereira MI, Goloni MR, Pires FC, Oliveira RS, da Rocha MA, et al. Mycobacterium tuberculosis
in a HIV-1-infected population from Southeastern Brazil in the HAART era. Trop Med Int Health 2011;16:67-73.
Fusco da Costa AR, Falkinham JO 3rd
, Lopes ML, Barretto AR, Felicio JS, Sales LH, et al.
Occurrence of nontuberculous mycobacterial pulmonary infection in an endemic area of tuberculosis. PLoS Negl Trop Dis 2013;7:e2340.
Lima CA, Gomes HM, Oelemann MA, Ramos JP, Caldas PC, Campos CE, et al.
Nontuberculous mycobacteria in respiratory samples from patients with pulmonary tuberculosis in the state of Rondônia, Brazil. Mem Inst Oswaldo Cruz 2013;108:457-62.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Viral suppression among HIV-positive patients on antiretroviral therapy in northwestern Nigeria: an eleven-year review of tertiary care centre records, January 2009–December 2019
| ||Suleiman Bello Abdullahi, Olayinka Rasheed Ibrahim, Abdulkadir Baba Okeji, Rabilu Iliyasu Yandoma, Ibrahim Bashir, Suleiman Haladu, Suleiman Ahmad Idris, T. I. A. Oseni, Bello Muhammad Suleiman, Mohammed Yahaya, Mabel Kamweli Aworh, Mu’awiyyah Babale Sufiyan |
| ||BMC Infectious Diseases. 2021; 21(1) |
|[Pubmed] | [DOI]|
||Using GIS to Address Epidemiologic Research Questions
| ||Ellen K. Cromley |
| ||Current Epidemiology Reports. 2019; |
|[Pubmed] | [DOI]|
||Mycobacterium avium: an overview
| ||Caroline Busatto,Júlia Silveira Vianna,Lande Vieira da Silva,Ivy Bastos Ramis,Pedro Eduardo Almeida da Silva |
| ||Tuberculosis. 2019; 114: 127 |
|[Pubmed] | [DOI]|